Search research articles
Contact Us
Filters
Showing results (41-50 of 97) with videos related to
Page
of 10
Sort By:
European Journal of Heart Failure
|
February 4, 2012
Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology
Kaspar Broch, Thor Ueland, Ståle H Nymo, et al.
Scientific Reports
|
March 20, 2024
No adverse association between exercise exposure and diffuse myocardial fibrosis in male endurance athletes
Kristoffer Andresen, Lars Gunnar Klæboe, Øyvind Haugen Lie, et al.
Atherosclerosis
|
January 22, 2026
Circulating B-cell activating factor in acute coronary syndromes - association with adverse outcomes and progression of heart failure
Thor Ueland, Geir Øystein Andersen, Sharanga Varathalingam, et al.
Journal of Cardiac Failure
|
July 10, 2017
Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure
Cristiane C K Mayerhofer, Thor Ueland, Kaspar Broch, et al.
American Heart Journal
|
August 21, 2025
DAPAgliflozin for Renal protection in Heart Transplant recipients. Rationale and design of the randomized controlled DAPARHT trial
Stine Holmen, Olivier Manintveld, Kevin Damman, et al.
Plos One
|
March 4, 2014
The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial
Kaspar Broch, Erik T Askevold, Erik Gjertsen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
June 21, 2023
A man in his seventies with fatigue and renal failure
Margrethe Flesvig Holt, August Flø, Vilde Bjørnø, et al.
Clinical Transplantation
|
May 24, 2020
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trial
Kaspar Broch, Einar Gude, Kristjan Karason, et al.
International Journal of Cardiology. Heart & Vasculature
|
October 27, 2025
Increased dipeptidyl peptidase 4 in patients with concomitant transthyretin cardiac amyloidosis and severe aortic stenosis
Margrethe Flesvig Holt, Annika E Michelsen, August Flø, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
July 22, 2024
Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial
Entela Bollano, Arne K Andreassen, Hans Eiskjaer, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 97) with videos related to
Sort By:
Page
of 10
European Journal of Heart Failure
|
February 4, 2012
Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology
Kaspar Broch, Thor Ueland, Ståle H Nymo, et al.
Scientific Reports
|
March 20, 2024
No adverse association between exercise exposure and diffuse myocardial fibrosis in male endurance athletes
Kristoffer Andresen, Lars Gunnar Klæboe, Øyvind Haugen Lie, et al.
Atherosclerosis
|
January 22, 2026
Circulating B-cell activating factor in acute coronary syndromes - association with adverse outcomes and progression of heart failure
Thor Ueland, Geir Øystein Andersen, Sharanga Varathalingam, et al.
Journal of Cardiac Failure
|
July 10, 2017
Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure
Cristiane C K Mayerhofer, Thor Ueland, Kaspar Broch, et al.
American Heart Journal
|
August 21, 2025
DAPAgliflozin for Renal protection in Heart Transplant recipients. Rationale and design of the randomized controlled DAPARHT trial
Stine Holmen, Olivier Manintveld, Kevin Damman, et al.
Plos One
|
March 4, 2014
The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial
Kaspar Broch, Erik T Askevold, Erik Gjertsen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
June 21, 2023
A man in his seventies with fatigue and renal failure
Margrethe Flesvig Holt, August Flø, Vilde Bjørnø, et al.
Clinical Transplantation
|
May 24, 2020
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trial
Kaspar Broch, Einar Gude, Kristjan Karason, et al.
International Journal of Cardiology. Heart & Vasculature
|
October 27, 2025
Increased dipeptidyl peptidase 4 in patients with concomitant transthyretin cardiac amyloidosis and severe aortic stenosis
Margrethe Flesvig Holt, Annika E Michelsen, August Flø, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
July 22, 2024
Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial
Entela Bollano, Arne K Andreassen, Hans Eiskjaer, et al.
Page
of 10